One perceives a certain confidence within the company, a readiness to embark upon further ventures. A considerable sum has been allocated to new capital projects, a pleasing indication of ambition. This visible commitment to expansion renders Enbridge a particularly attractive prospect for those seeking a secure, yet growing, income stream. It is, one might venture, a most sensible addition to a well-managed portfolio.
Everyone’s breathlessly anticipating what Jensen Huang, that magnificent showman, will say. He could announce they’ve discovered a way to power servers with hamsters on tiny treadmills, and the stock would still go up. But let’s not get carried away. Let’s look under the hood, shall we? Because when the music stops, somebody’s going to be left without a chair, and I suspect it won’t be Jensen.
This Newtyn fellow, according to a document filed with the SEC (a place full of very serious people and even more serious paperwork), has increased his pile of Array shares. He now owns 1,700,000 of them, which represents a rise of $23.6 million in value since last time. It’s a rather impressive collection, and suggests he thinks Array might be worth a bit more than some other folks do.
Still, one should not dismiss the possibility of profit. Not entirely. It’s a grim business, this chasing of dividends, like scavenging for crumbs beneath the table of pharmaceutical giants. But crumbs, when accumulated, can sustain a man. Or at least, a portfolio.
They increased their holding in the fourth quarter. That’s the official story. The numbers have gone up, of course. A hefty 120% over the year. Which, in my experience, usually means someone, somewhere, is trying very hard to convince you something is worth more than it is. The fund’s position increased by $60.94 million – a blend of actual investment and, let’s be honest, a bit of market froth. It’s like watching a magician; you know there’s a trick, but you’re still momentarily impressed by the disappearing rabbit.
The filing with the SEC confirms the transaction – $43.14 million sunk into a company down nearly 38% in a year. A bold move, or a desperate one? Newtyn now holds 4.53% of Integer, a stake built on the ruins of past optimism. One wonders if they consulted the assembly line workers, the ones who actually make the devices, before committing such a sum.
Transaction value is calculated based on the SEC Form 4 weighted average purchase price of $71.87; post-transaction value is based on the February 3, 2026 market close price of $71.87.
If you asked me where to put it, well, I’d say look at the companies that seem to know what everyone else is thinking before they do. Two of them, in particular. They’re busy building the future, or at least a very convincing imitation of one. Artificial intelligence. Sounds like science fiction, doesn’t it? It’s just business now.
The fine print says it was tied to an option exercise. A neat little dance where Willett cashed in some paper, then immediately sold the resulting shares. The weighted average price came in around $59.50. The market closed at $58.79 that day. A difference so small, it could have been lost in the static. It smelled less like a conviction, more like a pre-arranged agreement.
Which brings us to Rocket Lab. Rocket Lab (RKLB 7.50%). They’re trying, I’ll give them that. They’re launching things. Smaller things, admittedly. But launching. And they’ve managed to do it without, you know, exploding. Most of the time. It’s a start. They’ve grown revenue, they say, by 900% in five years. Okay. Fine. But is that good growth? Is it the kind of growth that justifies… well, anything?